Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06421844

A Prospective Study: Smart Phone Application for Measure Serum Bilirubin Through Sclera Images

A Prospective Study: A Computer Vision Model on a Smartphone Platform for Real-time Evaluation of Serum Bilirubin Through Sclera Images

Status
Recruiting
Phase
Study type
Observational
Enrollment
270 (estimated)
Sponsor
Air Force Military Medical University, China · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Accepted

Summary

The primary efficacy endpoints are the standard deviation and coefficient of determination (R2) between predicted and actual values for the bilirubin regression model, and the grading accuracy for the jaundice severity classification model. The secondary efficacy endpoint is the mean percentage error between predicted and actual bilirubin values. There are no relevant safety risks. Statistical differences for categorical variables (e.g., jaundice grading evaluation indicators) will be analyzed using the chi-square test or Fisher's exact probability test. For continuous variables (e.g., bilirubin prediction evaluation indicators), t-tests (normal distribution) or non-parametric tests (non-normal distribution) will be used. The 95% confidence interval for jaundice grading accuracy will be calculated using the Wilson method. The study duration is estimated to be 3 months.

Conditions

Timeline

Start date
2024-04-20
Primary completion
2024-06-20
Completion
2024-07-10
First posted
2024-05-20
Last updated
2024-05-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06421844. Inclusion in this directory is not an endorsement.